BioCentury | May 23, 2005
Finance

U.S. investment in Europe

...Partners; Sofinnova Partners; Auriga Partners; Credit Lyonnais Speedel Switzerland $40.4 Not disclosed ProStrakan U.K. $40.2 LMS Capital...
BioCentury | Nov 1, 2004
Finance

Ebb & Flow

...in-licensed from Cellegy (CLGY) (see BioCentury, July 19). The round was led by existing shareholders LMS Capital...
BioCentury | Oct 25, 2004
Financial News

ProStrakan raises L22 million

...ProStrakan (Galashiels, UK) raised L22 million ($39.6 million) in a venture round led by shareholders LMS Capital...
BioCentury | Jun 14, 2004
Company News

ProSkelia SA, Strakan deal

...Roland Baron will become president and CSO. Investors in Strakan include Warburg Pincus; 3i; and LMS Capital...
BioCentury | Jun 8, 2004
Top Story

Strakan to merge with ProSkelia

...and Isotard isosorbide to treat angina. Investors in Strakan include Warburg Pincus ; 3i; and LMS Capital...
Items per page:
1 - 5 of 5
BioCentury | May 23, 2005
Finance

U.S. investment in Europe

...Partners; Sofinnova Partners; Auriga Partners; Credit Lyonnais Speedel Switzerland $40.4 Not disclosed ProStrakan U.K. $40.2 LMS Capital...
BioCentury | Nov 1, 2004
Finance

Ebb & Flow

...in-licensed from Cellegy (CLGY) (see BioCentury, July 19). The round was led by existing shareholders LMS Capital...
BioCentury | Oct 25, 2004
Financial News

ProStrakan raises L22 million

...ProStrakan (Galashiels, UK) raised L22 million ($39.6 million) in a venture round led by shareholders LMS Capital...
BioCentury | Jun 14, 2004
Company News

ProSkelia SA, Strakan deal

...Roland Baron will become president and CSO. Investors in Strakan include Warburg Pincus; 3i; and LMS Capital...
BioCentury | Jun 8, 2004
Top Story

Strakan to merge with ProSkelia

...and Isotard isosorbide to treat angina. Investors in Strakan include Warburg Pincus ; 3i; and LMS Capital...
Items per page:
1 - 5 of 5